BSCs and Isolators: Selecting the Right Platform for Aseptic Workflows

Event Description

As aseptic processing needs for advanced therapies, small-batch pharmaceutical production, and sterility testing grow, it is paramount for involved parties to understand how to select the proper engineering controls for critical workflows.

This expert-led session from Labconco and SKAN will evaluate multiple types of aseptic engineering controls, including open systems (Class II Biosafety Cabinets and Laminar Flow Hoods) and closed systems (Aseptic Isolators). Attendees will learn core cGMP expectations for different engineering controls, gain an understanding of functional differences between engineering controls, and become knowledgeable about key facility design choices that influence cost and operational efficiency.

Learning Objectives

• Understand cGMP expectations for primary engineering controls used in aseptic processing

• Identify the key functional and operational differences between open engineering controls (BSCs, laminar flow hoods) and closed systems (isolators) used in aseptic workflows

• Evaluate the cost and facility-level implications when designing facilities for open and closed engineering controls

Watch On-Demand

Speakers

David Wasescha

Director of Biosafety Products

David Wasescha, Labconco Director of Biosafety Products for XPert systems & workstations, filtered glove boxes, inert glove boxes, combination glove boxes, and aseptic isolators.

Zoe Reilly

Senior Technical Expert - Sterility Assurance

Jeremy Sandler

Product Manager

Jeremy Sandler, PhD, is Labconco's Product Manager for biosafety and laminar flow products. He brings over 20 years of research experience in life sciences spanning microbiology, plant ecology, genetics, genomics, stem cells, and tissue regeneration. Jeremy is passionate about developing the most advanced and comfortable biosafety equipment for today's and tomorrow's scientists.